Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Status: FDA-approved (metabolic/weight indications) Weekly SC injection Available via prescription Caveat: GLP-1 side effects including liver, kidney, and pancreatic risks are detectable early with proper lab monitoring
Comment: Commenters expressed concerns with the proposed 340B accelerated offset and its reduction on the CY 2026 proposed rate increase
A larger share, 60% , cover GLP-1s for diabetes only, and 45% cover them for other FDA-approved conditions such as sleep apnea and cardiovascular disease
Some users report improvements within a few weeks, depending on usage consistency
Livermore DM, Mushtaq S, Warner M, Zhang J-C, Maharjan S, Doumith M, Woodford N
US$ 26.68
US$ 20.69
US$ 24.60
US$ 20.84
US$ 27.43
US$ 23.59
US$ 26.38
US$ 28.58
US$ 21.95
US$ 26.35
US$ 25.64
